News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PARMAR KUSH
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
4
| 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Sold 164,789 shares
@ $15, valued at
$2.5M
Sold 32,711 shares
@ $15, valued at
$490.7k
|
|
| 06/12/2023 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 05/19/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
| 03/09/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Sold 100,000 shares
@ $8.2, valued at
$820k
|
|
| 03/06/2023 |
3
| 5AM Partners VI, LLC (10% Owner) has filed a Form 3 on Enliven Therapeutics, Inc. |
| 02/28/2023 |
4
| 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Unknown transaction of 3,953,990 shares
@ $0
Unknown transaction of 487,333 shares
@ $0
Unknown transaction of 496,323 shares
@ $0 |
|
| 01/05/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 10,344 options to buy
@ $6.19, valued at
$64k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $1.88, valued at
$33.8k
|
|
| 06/16/2022 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 16,911 options to buy
@ $4.26, valued at
$72k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 11,918 options to buy
@ $6.06, valued at
$72.2k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Sold 139,539 shares
@ $13.05, valued at
$1.8M
Sold 70,461 shares
@ $13.05, valued at
$919.5k
|
|
| 01/13/2022 |
4
| 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 3,683,823 shares
@ $0
Converted 183,823 shares
@ $0
Bought 157,500 shares
@ $16, valued at
$2.5M
Bought 312,500 shares
@ $16, valued at
$5M
Converted 9,999,999 preferred shares
@ $0
Converted 2,525,000 preferred shares
@ $0
Converted 625,000 preferred shares
@ $0 |
|
| 01/06/2022 |
3
| 5AM Partners VI, LLC (10% Owner) has filed a Form 3 on CinCor Pharma, Inc. |
| 01/05/2022 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Granted 5,772 options to buy
@ $10.38, valued at
$59.9k
|
|
| 11/18/2021 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Sold 238,870 shares
@ $15.3, valued at
$3.7M
Sold 91,836 shares
@ $15.3, valued at
$1.4M
|
|
| 11/05/2021 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Converted 318,616 shares
@ $0
Converted 2,371,739 shares
@ $0
Converted 564,217 shares
@ $0
Converted 254,512 shares
@ $0
Converted 318,140 shares
@ $0
Bought 250,000 shares
@ $20, valued at
$5M
Converted 318,616 options to buy
@ $0
Converted 2,371,739 preferred shares
@ $0
Converted 564,217 preferred shares
@ $0
Converted 254,512 preferred shares
@ $0
Converted 318,140 preferred shares
@ $0 |
|
| 11/05/2021 |
3/A
| PARMAR KUSH (10% Owner) has filed a Form 3/A on Entrada Therapeutics, Inc. |
| 11/03/2021 |
4
| 5AM Ventures V, L.P. (10% Owner) has filed a Form 4 on Cabaletta Bio, Inc.|
Txns:
| Sold 258,456 shares
@ $13, valued at
$3.4M
Sold 36,544 shares
@ $13, valued at
$475.1k
|
|
| 11/01/2021 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 23,552 options to buy
@ $20, valued at
$471k
|
|
| 10/28/2021 |
3
| PARMAR KUSH (10% Owner) has filed a Form 3 on Entrada Therapeutics, Inc. |
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp|
Txns:
| Acquired 2,784,626 shares
@ $0
Acquired 790,714 shares
@ $0
Bought 615,384 shares
@ $13, valued at
$8M
Disposed of 1,795,946 options to buy
@ $0
Disposed of 8,742,654 options to buy
@ $0
Disposed of 7,192,795 options to buy
@ $0
Disposed of 5,034,955 options to buy
@ $0
Granted 13,440 options to buy
@ $13, valued at
$174.7k
|
|
| 07/29/2021 |
3
| PARMAR KUSH (10% Owner) has filed a Form 3 on Rallybio Corp |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 18,000 options to buy
@ $7.26, valued at
$130.7k
|
|
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|
|